Your browser doesn't support javascript.
loading
Circular RNA circESYT2 serves as a microRNA-665 sponge to promote the progression of hepatocellular carcinoma through ENO2.
Du, Wei; Li, Ying; Wang, Xufeng; Xie, Sunzhe; Ci, Hongfei; Zhou, Jiaming; Zhu, Ningqi; Chen, Zule; Zheng, Yan; Jia, Huliang.
Afiliação
  • Du W; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Li Y; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Wang X; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Xie S; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Ci H; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhou J; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhu N; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Chen Z; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
  • Zheng Y; Department of Pancreatic Surgery, Shanghai General Hospital, Shanghai Key Laboratory of Pancreatic Disease, Institute of Pancreatic Disease, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Jia H; Hepatobiliary Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Cancer Sci ; 115(8): 2659-2672, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38710213
ABSTRACT
Circular RNAs (circRNAs) have emerged as crucial regulators in tumor progression, yet their specific role in hepatocellular carcinoma (HCC) remains largely uncharacterized. In this study, we utilized high-transcriptome sequencing to identify the upregulation of circESYT2 (hsa_circ_002142) in HCC tissues. Functional experiments carried out in vivo and in vitro revealed that circESYT2 played a significant role in maintaining the growth and metastatic behaviors of HCC. Through integrative analysis, we identified enolase 2 (ENO2) as a potential target regulated by circESYT2 through the competitive endogenous RNA sponge mechanism. Additional gain- or loss-of-function experiments indicated that overexpression of circESYT2 led to a tumor-promoting effect, which could be reversed by transfection of microRNA-665 (miR-665) mimic or ENO2 knockdown in HCC cells. Furthermore, the direct interaction between miR-665 and circESYT2 and between miR-665 and ENO2 was confirmed using RNA immunoprecipitation, FISH, RNA pull-down, and dual-luciferase reporter assays, highlighting the involvement of the circESYT2/miR-665/ENO2 axis in promoting HCC progression. These findings shed light on the molecular characteristics of circESYT2 in HCC tissues and suggest its potential as a biomarker or therapeutic target for HCC treatment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfopiruvato Hidratase / Regulação Neoplásica da Expressão Gênica / Carcinoma Hepatocelular / Progressão da Doença / MicroRNAs / RNA Circular / Neoplasias Hepáticas Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfopiruvato Hidratase / Regulação Neoplásica da Expressão Gênica / Carcinoma Hepatocelular / Progressão da Doença / MicroRNAs / RNA Circular / Neoplasias Hepáticas Limite: Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article